Medpace Holdings, Inc.
MEDP
$428.03
$11.992.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.36% | 9.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.36% | 9.38% | |||
| Cost of Revenue | -2.25% | 0.27% | |||
| Gross Profit | 11.13% | 13.43% | |||
| SG&A Expenses | -6.58% | 3.04% | |||
| Depreciation & Amortization | 1.16% | 0.50% | |||
| Other Operating Expenses | 16.03% | 16.49% | |||
| Total Operating Expenses | 7.16% | 8.62% | |||
| Operating Income | 8.08% | 12.25% | |||
| Income Before Tax | 9.80% | 14.69% | |||
| Income Tax Expenses | -31.55% | -7.52% | |||
| Earnings from Continuing Operations | 21.59% | 23.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.59% | 23.13% | |||
| EBIT | 8.08% | 12.25% | |||
| EBITDA | 7.75% | 11.63% | |||
| EPS Basic | 20.93% | 25.16% | |||
| Normalized Basic EPS | 9.20% | 16.59% | |||
| EPS Diluted | 20.80% | 24.52% | |||
| Normalized Diluted EPS | 9.24% | 15.99% | |||
| Average Basic Shares Outstanding | 0.55% | -1.63% | |||
| Average Diluted Shares Outstanding | 0.51% | -1.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||